Stock ACON ACLARION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Aclarion, Inc.

Equities

ACON

US6551872012

Delayed Nasdaq
Other stock markets
 02:07:34 2024-05-23 pm EDT 		5-day change 1st Jan Change
0.313 USD -6.29% Intraday chart for Aclarion, Inc. -3.96% -90.16%
Feb. 26 Top Midday Decliners MT
Feb. 21 Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
AQ
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs
AQ
Aclarion Announces Closing of $3.0 Million Public Offering
AQ
Top Midday Decliners
MT
Aclarion Announces Pricing of $3.0 Million Public Offering
AQ
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership
AQ
Top Premarket Decliners
MT
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast
MT
US Futures Nudge Lower in Friday's Premarket Ahead of Fed Inflation Data
MT
Wall Street Set to Open Flat as Investors Eye Key Manufacturing Index
MT
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
AQ
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution
AQ
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution
CI
Top Midday Gainers
MT
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan
AQ
Aclarion and Atec Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan
CI
Aclarion Announces Reverse Stock Split
AQ
Aclarion to Implement 1-for-16 Reverse Stock Split; Shares Rise
MT
Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACON Stock
  4. News Aclarion, Inc.